Enter your login e-mail to the account
Search
- Idiopathic pulmonary fibrosis – emerging therapeutic options
MUDr. Bohumil Matula
(2/2015, Review articles )
- How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Zriedkavý nádor hrudníka: malígny pleurálny mezotelióm
MUDr. Lucia Denková, MUDr. František Sándor, PhD., FCCP
(3/2018, Main topic ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes )